lung cancer
Conditions
Interventions
Group A:The HANS-100B acupoint nerve stimulator was applied with alternating 2/100 Hz stimulation at an intensity of 2-3 times the sensory threshold.
Group B:The HANS-100B acupoint nerve stimulator was properly connected to the patient but without electrical current delivery.
Sponsors
Department of Anesthesiology, the First Affiliated Hospital of Wenzhou Medical University
Eligibility
Sex/Gender
All
Age
18 Years to 75 Years
Inclusion criteria
Inclusion criteria: 1: Diagnosed with pulmonary lesions and scheduled for elective video-assisted thoracoscopic surgery (VATS) lobectomy; 2: Aged 18-75 years, regardless of sex; 3: Body mass index (BMI): 18 kg/m² < BMI <= 31 kg/m²; 4: American Society of Anesthesiologists (ASA) physical status classification I-III.
Exclusion criteria
Exclusion criteria: 1: Contraindications to transcutaneous electrical acupoint stimulation (TEAS) present; 2: Patients with significant abnormalities in pulmonary, hepatic, renal or coagulation function; 3: Preoperative severe central nervous system disorders or major psychiatric diseases; 4: Comorbid severe cardiovascular or cerebrovascular diseases; 5: History of radiotherapy, chemotherapy or immunosuppressive drug therapy; 6: Intraoperative occurrence of major hemorrhage or other severe complications.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Oxygenation index; | — |
Secondary
| Measure | Time frame |
|---|---|
| The IL-8 content in the plasma;Visual Analogue Scale (VAS) scores;The effective number of compressions of PCA;Time-to-Event Outcomes;Occurrences of pulmonary complications;QoR-15; | — |
Countries
China
Contacts
Public ContactWang Junlu
epartment of Anesthesiology, the First Affiliated Hospital of Wenzhou Medical University
Outcome results
None listed